Mesoblast (MEOBF) Cash from Operations (2014 - 2023)

Mesoblast has disclosed Cash from Operations across 10 years of filings, most recently posting $110.3 million for Q2 2023.

• In Q2 2023, Cash from Operations rose 893.58% year-over-year to $110.3 million; the TTM figure through Jun 2023 stood at $63.3 million (up 315.32% YoY), while the FY2026 annual figure was $43.8 million, down 12.26% from the prior year.
• Cash from Operations came in at $110.3 million for Q2 2023 at Mesoblast, up from -$77.7 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $110.3 million in Q2 2023 to a low of -$77.7 million in Q1 2023.
• Average Cash from Operations over 5 years is -$9.9 million, with a median of -$17.6 million recorded in 2019.
• Year-over-year, Cash from Operations tumbled 762.95% in 2019 and surged 893.58% in 2023.
• Over 5 years, Cash from Operations stood at -$16.9 million in 2019, then sank by 81.08% to -$30.6 million in 2020, then soared by 40.42% to -$18.2 million in 2021, then jumped by 190.31% to $16.5 million in 2022, then soared by 570.11% to $110.3 million in 2023.
• Per Business Quant data, the three most recent Cash from Operations figures were $110.3 million in Q2 2023, -$77.7 million in Q1 2023, and $16.5 million in Q4 2022.